Page last updated: 2024-11-02

pamidronate and Albers-Schoenberg Disease

pamidronate has been researched along with Albers-Schoenberg Disease in 8 studies

Research Excerpts

ExcerptRelevanceReference
"Sixty-two (52."1.33Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. ( Broumand, V; Fortin, M; Marx, RE; Sawatari, Y, 2005)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wehrhan, F1
Hyckel, P1
Amann, K1
Ries, J1
Stockmann, P1
Schlegel, K1
Neukam, F1
Nkenke, E1
Whyte, MP1
Wenkert, D1
Clements, KL1
McAlister, WH1
Mumm, S1
Glorieux, FH1
Rauch, F1
Shapiro, JR1
Bjarnason, NH1
Tanvetyanon, T1
Ward, K1
Cowell, CT1
Little, DG1
Marx, RE1
Sawatari, Y1
Fortin, M1
Broumand, V1
Rawlinson, PS1
Green, RH1
Coggins, AM1
Boyle, IT1
Gibson, BE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631]Phase 280 participants (Actual)Interventional2015-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

8 other studies available for pamidronate and Albers-Schoenberg Disease

ArticleYear
Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
    Oral diseases, 2011, Volume: 17, Issue:4

    Topics: Alkaline Phosphatase; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Morphogen

2011
Bisphosphonate-induced osteopetrosis.
    The New England journal of medicine, 2003, Jul-31, Volume: 349, Issue:5

    Topics: Alkaline Phosphatase; Bone Density; Bone Marrow; Calcium; Child; Diphosphonates; Humans; Male; Osteo

2003
Bisphosphonates in children with bone diseases.
    The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21

    Topics: Animals; Bone Density; Child; Diphosphonates; Humans; Knee Joint; Male; Osteogenesis Imperfecta; Ost

2003
Bisphosphonates in children with bone diseases.
    The New England journal of medicine, 2003, Nov-20, Volume: 349, Issue:21

    Topics: Bone Density; Bone Resorption; Child; Diphosphonates; Drug Administration Schedule; Humans; Ibandron

2003
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
    Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1

    Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazol

2005
Quantification of metaphyseal modeling in children treated with bisphosphonates.
    Bone, 2005, Volume: 36, Issue:6

    Topics: Adolescent; Bone Development; Bone Diseases; Child; Child, Preschool; Diphosphonates; Female; Femur;

2005
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2005, Volume: 63, Issue:11

    Topics: Abscess; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breas

2005
Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
    Archives of disease in childhood, 1991, Volume: 66, Issue:5

    Topics: Bone Marrow Transplantation; Calcitonin; Child, Preschool; Diphosphonates; Female; Humans; Hypercalc

1991